¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glycogen storage disease type VII"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • collagen disease
    Äݶó°Õº´
  • collagen-vascular disease
    Äݶó°ÕÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
  • complicating disease
    ÇÕº´Áúȯ
  • compressed-air disease
    °¨¾Ðº´
  • congenital heart disease
    ¼±Ãµ½ÉÀ庴
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • constitutional disease
    üÁúº´
  • constrictive heart disease
    ÇùÂø½ÉÀ庴
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • bauxite fume disease
    º¸¿ÀÅ©»çÀÌÆ®Áõ±âº´
  • bird fancier¡¯s disease
    Á¶·ù»çÀ°ÀÚº´
  • bleeder¡¯s disease
    (¢¡hemophilia) Ç÷¿ìº´
  • blue disease
    û»öº´
  • Burger¡¯s disease
    ¹ö°Åº´
  • cadmium worker¡¯s disease
    Ä«µå¹ÅÁ÷°øº´
  • caisson disease
    Àá¼öº´, ÀáÇÔº´
  • caloric disease
    °í¿Âº´
  • carcinoid heart disease
    À¯¾Ï½ÉÀ庴
  • cardiovascular disease
    ½ÉÀåÇ÷°üº´
  • cat-scratch disease
    °í¾çÀ̱ÜÈûº´
  • celiac disease
    ¸¸¼º¼ÒÈ­Àå¾ÖÁõ, ¼Ò¾ÆÁö¹æº¯(Áõ), º¹ºÎÁúº´
  • central core disease
    Áß½ÉÇÙº´
  • cerebrovascular disease
    ³úÇ÷°üº´, ³úÇ÷°üÁúȯ
  • cervical disease
    Àڱøñº´, ÀڱðæºÎº´, ÀڱðæºÎÁúȯ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Addisons disease
    ¾Æµð¼Õ º´
  • Addisons disease
    ¾Öµð½¼º´ ºÎ½Å±â´ÉºÎÀü .
  • Aleutian mink disease virus
    ¾Ë·ù»ê¹ÖÅ©º´ ¹ÙÀÌ·¯½º
  • Alport s disease
    ¾ËÆ÷¿ÀÆ®º´.
  • Alzheimer disease
    ¾ËÂêÇÏÀÌ¸Ó Áúȯ
  • Alzheimer s disease
    ¾ËÂêÇÏÀ̸Ӻ´.
  • Alzheimers disease
    ¾ËÂêÇÏÀ̸Ӻ´.
  • American hookworm disease
    ¾Æ¸Þ¸®Ä«±¸Ã溴.
  • Aujeszkys disease virus
    ¿ÀÁ¦½ºÅ°º´¹ÙÀÌ·¯½º
  • B rgers disease
    ¹ö°Åº´.
  • Balos disease
    ¹ß·Îº´.
  • Bantis disease
    ¹ÝƼº´ ¡ì°£Á¾Ã¢¼º ºñÁ¾¡í.
  • Beards disease
    º£¾îµåº´=¼è¾àÁõÈıº(neurasthenia)
  • Beh ets disease
    º£Ã¼Æ®º´
  • Behcets disease
    º£¼¼Æ®º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • fibrous type dermatofibroma
    ¼¶À¯Çü ÇǺΠ¼¶À¯Á¾
  • fibrous type of lymphatic vessel
    ¼¶À¯Çü¸²ÇÁ°ü
  • fibrous type of vein
    ¼¶À¯ÇüÁ¤¸Æ
  • foreign body-type giant cell
    À̹°Çü °Å´ë¼¼Æ÷(¡­ËÝÓÞá¬øà)
  • glomus type of arteriovenous anastomosis
    Å丮Çüµ¿Á¤¸Æ¿¬°á
  • golgi type i neuron
    ±äÃà»è½Å°æ¼¼Æ÷
  • golgi type ii neuron
    ªÀºÃà»è½Å°æ¼¼Æ÷
  • growth onset type diabetes
    Ãʱâ´ç´¢º´.
  • hebephrenic type
    ÆÄ°úÇü(÷òÍþúþ)
  • hemangioma,granulation tissue type
    À°¾ÆÁ¶Á÷Çü
  • hemochorial type
    À¶Ç÷¸ðÇü(ëÖúìÙ¾úþ).
  • hemoglobin C type
    CÇü Ç÷»ö¼Ò
  • hemoglobin E type
    E Çü Ç÷»ö¼Ò
  • hepatitis,type a
    A Çü
  • hepatitis,type b
    B Çü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
DASD Direct Access Storage Device
  = RAM
CSC blow on blow (administration of small amounts of drugs at short intervals) [Fr. coup sur coup]; coll...
DASD direct access storage device
DSO digital storage oscilloscope; distal subungual onychomycosis
EDSR electronic document storage and retrieval
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
HIV-2 Human Immunodeficiency Virus type 1 and type 2
HSV 2 herpes simplex virus type 1 or type 2
Type 1 type
type I type B
CMT1 Charcot--Marie--Tooth disease type 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • African sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´
  • air space disease
    °ø°£ Áúȯ
  • Akureyri disease
    ¾ÆÄí·¹À̸®º´
    ¾ç¼º ±ÙÅë ³úô¼ö¿°. ºÏ¾ÆÀ̽½¶õµå ¸¶À»ÀÇ À̸§À» µý °ÍÀÌ´Ù.
  • albers-schonberg disease
    º£¸£½º-½¨º£¸£Å©º´
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ
    1. ¾Ë·¹¸£±â´Â ¸é¿ª ¹ÝÀÀÀÇ º´Àû °úÁ¤À¸·Î¼­ ±× Á¤Àǰ¡ ³»·ÁÁ® ÀÖ°í, ¹ßº´ ±âÀü¿¡¼­ ¥°Çü, ¥±Çü, ¥²Çü ¹× ¥³ÇüÀ¸·Î ºÐ·ùµÇ¾î ÀÖ´Ù. ¥°ÇüÀº IgE classÀÇ Ç×ü, ¥±ÇüÀº IgG ¹× IgM classÀÇ Ç×ü, ¥²ÇüÀº ¸é¿ªº¹ÇÕü, ¥³ÇüÀº °¨ÀÛ¸²ÇÁ±¸°¡ °¢°¢ ƯÀÌÀûÀÎ ¸é¿ª¹ÝÀÀ ÀÎÀÚÀÌ´Ù. ÀÌ º´Àû °úÁ¤ÀÇ °á°ú·Î ¹ß»ýÇÏ´Â ÁúȯÀ» ¾Ë·¹¸£±â¼º ÁúȯÀ̶ó°í ºÎ¸¥´Ù. ¥°Çü ¾Ë·¹¸£±â Áúȯ¿¡´Â ±â°üÁö õ½Ä, µÎµå·¯±â, ¾Ë·¹¸£±â¼º ºñ¿°°ú °ïÃæ ¾Ë·¹¸£±â, ¥±Çü ¾Ë·¹¸£±â¿¡´Â Ç÷¾×Çü ºÎÀûÇÕ ¿ëÇ÷¼º ºóÇ÷, ¾Ë·¹¸£±â¼º Ç÷¼ÒÆÇ ¹éÇ÷±¸ °¨¼ÒÁõ µî, ¥²Çü ¾Ë·¹¸£±â¿¡´Â Ç÷ûº´, ³óºÎÁõ°ú »ç±¸Ã¼ ½Å¿° µî, ¥³Çü ¾Ë·¹¸£±â¿¡´Â øÃ˼º ÇǺο°, °áÇÙÀ» µé ¼ö ÀÖ´Ù. ±âŸ ¾î¶² ÇüÀÇ ¾Ë·¹¸£±â°¡ °ü¿©Çϰí ÀÖ´ÂÁö ºÐ¸íÈ÷ ±¸º°Àº ÇÒ ¼ö ¾øÁö¸¸ °¢Á¾ ±³¿øº´À̳ª ÀÚ°¡¸é¿ª Áúȯµµ ¾Ë·¹¸£±â¼º ÁúȯÀÇ ¹üÁÖ¿¡ µé¾î°£´Ù. 2. ¾Ë·¹¸£±â¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ´Â º´ÀÇ ÃÑĪ. Ç÷ûº´, ²É°¡·çº´, ¾Ë·¹¸£±â¼º ºñ¿°, µÎµå·¯±â, ¾à¹° ¾Ë·¹¸£±â, ½ÀÁø µîÀÌ ÀÌ¿¡ ¼ÓÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • Almeida's disease
    ¾Ë¸ÞÀÌ´Ùº´
    ³²¹ÌÀÇ ºÐ¾Æ±ÕÁõ.
  • Andes disease
    ¾Èµ¥½º »ê¸Æº´
    ¾Èµ¥½º »ê¸ÆÀ» Ⱦ´ÜÇÏ´Â »ç¶÷µéÀÌ °É¸®´Â È«¹Ý Áõ»óÀ» Ư¡À¸·Î ÇÏ´Â »óÅÂ.
  • angiospasmodic disease
    Ç÷°ü ¿¬Ã༺ Áúȯ
  • aortic valve disease
    ´ëµ¿¸ÆÆÇ Áúȯ
  • Aran-Duchenne disease
    ¾Æ¶û-µÚ½Ã¿£´Àº´
    µ¿ÀǾî=s
  • arbovirus disease
    ¾Æ¸£º¸ ¹ÙÀÌ·¯½ºº´
  • arthropod viral disease
    ¾Æ¸£º¸ ¹ÙÀÌ·¯½º Áúȯ, ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½º Áúȯ, ÀýÁöµ¿¹° ¸Å°³¼º ¹ÙÀÌ·¯½º Áúȯ
    µ¿ÀǾî=arbovirus disease.
  • atopic disease
    ¾ÆÅäÇǼº Áúȯ
    À¯ÀüÀû ¼ÒÀÎÀ» °¡Áö ÀÓ»óÀû °ú¹ÎÁõ »óÅ ¶Ç´Â ¾Ë·¯Áö. Áï ¾î¶² Á¾·ùÀÇ ¾Ë·¯Áö¸¦ ÀÏÀ¸Å°±â ½¬¿î °æÇâÀº À¯ÀüµÇ³ª, ƯÀÌÀûÀÎ ÀÓ»óÇüÀÎ °íÃÊ¿­, õ½Ä, ½ÀÁø µîÀº À¯ÀüµÇÁö ¾Ê´Â´Ù. reaginÀ̶ó´Â ÀÌ»óÇÑ ÇüÀÇ Ç×ü°¡ Æ÷ÇԵǾî ÀÖÀ¸³ª, À̰ÍÀº ¸é¿ª ±Û·ÎºÒ¸°
  • autoallergic disease
    ÀÚ°¡ ¾Ë·¹¸£±â Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
childhood type tuberculosis First infection by Mycobacterium tuberculosis, typically seen in children but also occurs in adults, characterised in the lungs by the formation of a primary complex consisting of small peripheral pulmonary focus with spread to hilar or paratracheal lymph nodes; may cavitate or heal with scarring or may progress.
Synonym: childhood type tuberculosis.
(05 Mar 2000)
pernicious anaemia type rubriblast The earliest of four maturation stages of the megaloblast.
See: erythroblast.
Synonym: pernicious anaemia type rubriblast.
(05 Mar 2000)
persecutory type of paranoid disorder One of the most common of the types of paranoid disorders, it involves a single theme or series of connected themes, such as being conspired against, cheated, spied on, followed, poisoned or drugged, maligned, harassed, or obstructed in the pursuit of long-term goals; small slights may be exaggerated and become the focus of a delusional system.
See: paranoia.
Compare: paranoid personality disorder.
(05 Mar 2000)
river-type fish <marine biology> Anadromous fish that rear for a year or more in rivers.
(23 Aug 1998)
Romanovsky type stain <technique> Composite histological stains including methylene blue, Azure A or B and eosin, sometimes with other stains.
Examples are Giemsa, Wright's and Leishman's stain.
(18 Nov 1997)
wild type <genetics> The naturally-occuring, normal, non-mutated version of a gene.
The original parent strain of a virus, bacteria, fruit fly, mouse, or other laboratory test organism. Often refers to how organisms are found naturally, in the wild, before mutations were induced by researchers.
(09 Oct 1997)
wild-type strain A strain found in nature or a standard strain.
See: auxotrophic strains, prototrophic strains.
(05 Mar 2000)
MPGN type i A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
mpgn type II A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure. Membranoproliferative glomerulonephritis (MPGN) has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
(27 Sep 1997)
woodbury-type 1. A process in photographic printing, in which a relief pattern in gelatin, which has been hardened after certain operations, is pressed upon a plate of lead or other soft metal. An intaglio impression in thus produced, from which pictures may be directly printed, but by a slower process than in common printing.
2. A print from such a plate.
Origin: After the name of the inventor, W. Woodbury.
Source: Websters Dictionary
(01 Mar 1998)
multiple endocrine neoplasia type 1 A rare syndrome characterised by hyperplasia and/or neoplasms of the pituitary, parathyroid glands, and pancreatic islets. Hyperparathyroidism occurs in 90% of the cases and is usually the first manifestation of the syndrome. The most frequent pancreatic manifestation is gastrinoma typically leading to zollinger-ellison syndrome. The appearance of this condition has been limited to the loss of allelic heterozygosity at the 11q13 locus on the long arm of chromosome 11. Patients overall exhibit long survival times. Chemotherapy is rare and surgical management is generally dependent on the genetic expression in individual patients.
(12 Dec 1998)
multiple endocrine neoplasia type 2 <syndrome> This is a hereditary disorder in which two or more of the following glands: thyroid, adrenal or parathyroid, develop overgrowth (hyperplasia) or malignant cells (cancer). The underlying cause is genetic and a positive family history for this illness is a risk factor.
Incidence: approximately 3 in 100,000 people in the general population.
(27 Sep 1997)
multiple endocrine neoplasia type 2a A type of multiple endocrine neoplasia characterised by a virtually 100% incidence of medullary thyroid carcinoma, a 50% incidence of pheochromocytoma, and a lesser incidence of parathyroid adenomas associated with hyperparathyroidism. The condition is always transmitted through autosomal dominant inheritance. Genetic testing can identify individuals with the trait in early infancy. Treatment is usually excision of the enlarged parathyroid glands.
(12 Dec 1998)
multiple endocrine neoplasia type 2b A type of multiple endocrine neoplasia occurring as an isolated congenital presentation or as a distinct autosomal dominant disease. It is characterised by the 100% incidence of medullary thyroid carcinoma and frequent pheochromocytomas; patients seldom exhibit hyperparathyroidism. It is distinguished from men 2a by its characteristic physical appearance resulting from numerous neural defects including mucosal neuromas of the eyelids, lips, and tongue. The neural abnormalities also include widespread neurogangliomatosis of the gastrointestinal tract leading to abnormal gut motility. Treatment usually requires total thyroidectomy following evaluation for the presence of pheochromocytomas.
(12 Dec 1998)
multiple lipoprotein-type hyperlipidaemia <biochemistry> Inherited as a defective gene, this disorder is characterised by elevations in serum cholesterol and/or triglycerides. There are often multiple types of lipoproteins (LDL) elevated in one family. This condition is associated with an increased risk of cardiovascular disease.
Origin: Gr. Haima = blood
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á